Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies-Reference-Cited by-同舟云学术

Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies

Published:2016-10-01 Issue:12 Volume:39 Page:1175-1187
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Raschi Emanuel,Bianchin Matteo,Ageno Walter,De Ponti Roberto,De Ponti Fabrizio

Funder

Authors at the University of Bologna are supported by Institutional Research Funds (Ricerca Fondamentale Orientata).

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-016-0464-3.pdf

Reference110 articles.

1. Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism. JAMA. 2014;311(7):717–28.

2. Steinberg BA, Piccini JP. Anticoagulation in atrial fibrillation. BMJ. 2014;348:g2116.

3. Lip GY, Lane DA. Stroke prevention in atrial fibrillation: a systematic review. JAMA. 2015;313(19):1950–62.

4. Verheugt FW, Granger CB. Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. Lancet. 2015;386(9990):303–10.

5. Yeh CH, Fredenburgh JC, Weitz JI. Oral direct factor Xa inhibitors. Circ Res. 2012;111(8):1069–78.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Prescribing: Direct oral anticoagulants;BMJ;2024-08-30

2. Direct oral anticoagulants vs Vitamin-K antagonists in solid organ transplant recipients: A systematic review and meta-analysis;Pakistan Journal of Medical Sciences;2024-05-22

3. Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study;Advances in Therapy;2024-04-24

4. Dabigatran-related serious medication errors: an analysis using data from VigiBase;European Journal of Clinical Pharmacology;2024-01-29

5. Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients;British Journal of Clinical Pharmacology;2023-11-24